Concepedia

F. Dalenc

FD

Statistics

Publications

4

Citations

100

H-Index

4

Active since

2021

Affiliations

UNC Lineberger Comprehensive Cancer Center(Current)

Institut Claudius Regaud

University of North Carolina at Chapel Hill

Institut de Cancérologie de l'Ouest

Institut Curie

F. Dalenc is an author at UNC Lineberger Comprehensive Cancer Center specializing in oncology, pharmacology, and breast oncology.

Publications per year

2021–2024

4

Publications

4

Sacituzumab govitecan in metastatic triple-negative breast cancer

F. Dalenc, L.A. Carey, J. O apos Shaughnessy et al. · UNC Libraries · 2021 · 55 citations · Full text

, , +17

340O Efficacy, safety and biomarker analysis of ICARUS-BREAST01: A phase II study of patritumab deruxtecan (HER3-DXd) in patients (pts) with HR+/HER2- advanced breast cancer (ABC)

Barbara Pistilli, Luisa Pierotti, M. Lacroix-Triki et al. · Annals of Oncology · 2024 · 21 citations · Full text

, , +16

238MO PROMENADE: PembROlizuMab for early triple negative ER-low breast caNcer, reAl worlD frEnch cohort

François Cherifi, Luc Cabel, C. Bousrih et al. · Annals of Oncology · 2024 · 13 citations · Full text

, , +9

Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer

P. Aftimos, L. Vahdat, V. Diéras et al. · UNC Libraries · 2021 · 11 citations · Full text

, , +16

1–4 of 4